|1.||Takano, Hirohisa: 7 articles (04/2010 - 03/2005)|
|2.||Yoshikawa, Toshikazu: 6 articles (07/2009 - 03/2005)|
|3.||Yanagisawa, Rie: 6 articles (07/2009 - 03/2005)|
|4.||Sun, Zhijun: 5 articles (04/2013 - 01/2011)|
|5.||Sun, Xin: 5 articles (04/2013 - 01/2011)|
|6.||Sato, Hiroyuki: 5 articles (07/2009 - 03/2005)|
|7.||Su, Lei: 4 articles (08/2015 - 03/2009)|
|8.||Yang, Yu: 4 articles (02/2015 - 11/2011)|
|9.||Qiu, Wei: 4 articles (02/2015 - 11/2011)|
|10.||Tsujino, Takeshi: 4 articles (12/2013 - 04/2005)|
01/01/2007 - "Short-term (10 minutes) administration of ulinastatin showed a significant reduction in the incidence of post-ERCP pancreatitis in one randomized controlled trial. "
06/01/2014 - "Ulinastatin is a drug used effectively to alleviate symptoms and improve the pathophysiology of various types of pancreatitis. "
07/01/2013 - "Ulinastatin has been shown to be effective for the prevention of pancreatitis following endoscopic retrograde cholangiopancreatography. "
01/01/2006 - "Protective effects of ulinastatin on proliferation and cytokine release of splenocytes from rats with severe acute pancreatitis."
11/01/2010 - "A meta-analysis of all published randomized clinical trials was performed to evaluate the efficacy of ulinastatin on post-ERCP pancreatitis. "
11/01/2013 - "Ulinastatin was also found to be effective in ameliorating sepsis-related ALI, a syndrome most frequent and fatal in sepsis. "
09/01/2012 - "However, it is unknown if Ulinastatin treatment could result in protective effects for sepsis. "
07/01/2013 - "The aim of the present study was to determine the efficacy of ulinastatin (UTI) for the treatment of sepsis and to investigate the associated molecular mechanisms. "
03/01/2008 - "Urinary trypsin inhibitor treatment ameliorates acute lung and liver injury resulting from sepsis in a rat model."
12/01/2015 - "Randomized clinical trials on treatment of sepsis with the combination of ulinastatin and Tα1, compared with placebo, were reviewed. "
03/01/1999 - "Protective effects of ulinastatin against ischemia-reperfusion injury."
12/01/2011 - "Ulinastatin improved cardiac function and reduced infarct size after regional ischemia/reperfusion injury. "
07/01/2011 - "Addition of ulinastatin to preservation solution promotes protection against ischemia-reperfusion injury in rabbit lung."
12/01/2011 - "Ulinastatin showed a myocardial protective effect after regional ischemia/reperfusion injury in an in vivo rat heart model. "
12/01/2011 - "Myocardial protective effect by ulinastatin via an anti-inflammatory response after regional ischemia/reperfusion injury in an in vivo rat heart model."
07/22/2004 - "Ulinastatin greatly improved renal function and provides remarkable protection on renal ultrastructure after ischemia-reperfusion of kidney in rats."
09/01/1989 - "2) In canine experimental model of renal ischemia, ulinastatin significantly improved urine volume and urine NAG levels. "
11/01/1998 - "Evidence of neutrophil involvement in the protective effects of urinary trypsin inhibitor against ischemia reperfusion in vitro."
08/01/2015 - "Ulinastatin treatment inhibited ischemia-induced apoptosis by suppressing apoptosis-associated molecules, and thus ameliorated ischemia-induced short-term memory impairment. "
03/01/2014 - "The aim of this paper was to investigate the mechanism of ulinastatin's protection of lung from injury caused by lower limb ischemia-reperfusion in a rat model. "
11/02/2005 - "[Protective effects of ulinastatin against multiple organic damage after severe burn injury: experimental and clinic studies]."
01/01/2006 - "Urinastatin has protective effects on multiple organs in severe burn injury."
01/01/2006 - "To investigate the protective effects of urinastatin on organ function in severe burn. "
01/01/2006 - "[Protective effects of urinastatin on organ function in patients with severe burn]."
08/01/2008 - "The clinical and experimental data showed that ulinastatin relieved myocardial damage from severe burn. "
|1.||urinastatin (MR 20)
|2.||Protease Inhibitors (Protease Inhibitor)
|3.||Leukocyte Elastase (Neutrophil Elastase)
|7.||Anti-Bacterial Agents (Antibiotics)
|9.||Somatostatin (Somatotropin Release-Inhibiting Factor)
|1.||Fluid Therapy (Oral Rehydration Therapy)
|2.||Cardiopulmonary Bypass (Heart-Lung Bypass)